The role of angiotensin receptor blockers in preventing cognitive decline and the progression of dementia, including AD, is strengthened by this study. A well-designed randomized controlled study involving a heterogeneous population sample should follow, with emphasis placed on the definition of AD and dementia, as well as cognitive outcome measures. The possible mechanisms of action of angiotensin receptor blockers on cerebral function and neurobiology should be further elucidated.
Aging health. 2010;6(3):85-287. © 2010
Future Medicine Ltd.
Cite this: Angiotensin Receptor Blockers: Do They Protect Against Dementia and Alzheimer’s Disease in the Elderly? - Medscape - Jun 01, 2010.